Inventor · disambiguated record
Norbert Purro
Also filed as: PURRO NORBERT
19 granted patents·16 pending applications·304 citations·filing 2005–2024
96Inventor score
Top patents by PatentIndex Score
35 records- 0199US9725455B1Crystalline forms of a bruton's tyrosine kinase inhibitorPHARMACYCLICS LLC·Filed 2017·Granted Aug 8, 2017·25 cites·13 claims
- 0299US9713617B2Crystalline forms of a Bruton's tyrosine kinase inhibitorPHARMACYCLICS LLC·Filed 2016·Granted Jul 25, 2017·28 cites·41 claims
- 0398US10125140B1Crystalline forms of a bruton's tyrosine kinase inhibitorPHARMACYCLICS LLC·Filed 2018·Granted Nov 13, 2018·18 cites·4 claims
- 0498US9828383B1Crystalline forms of a bruton's tyrosine kinase inhibitorPHARMACYCLICS LLC·Filed 2017·Granted Nov 28, 2017·20 cites·31 claims
- 0598US9296753B2Crystalline forms of a Bruton's tyrosine kinase inhibitorPHARMACYCLICS LLC·Filed 2013·Granted Mar 29, 2016·84 cites·18 claims
- 0697US10961251B1Crystalline forms of a Bruton's tyrosine kinase inhibitorPHARMACYCLICS LLC·Filed 2020·Granted Mar 30, 2021·4 cites·14 claims
- 0797US10294231B2Crystalline forms of a Bruton's tyrosine kinase inhibitorPHARMACYCLICS LLC·Filed 2018·Granted May 21, 2019·11 cites·28 claims
- 0897US10106548B2Crystalline forms of a Bruton's tyrosine kinase inhibitorPHARMACYCLICS LLC·Filed 2018·Granted Oct 23, 2018·13 cites·30 claims
- 0997US9540382B2Crystalline forms of a Bruton's tyrosine kinase inhibitorPHARMACYCLICS LLC·Filed 2013·Granted Jan 10, 2017·43 cites·31 claims
- 1096US10294232B2Crystalline forms of a Bruton's tyrosine kinase inhibitorPHARMACYCLICS LLC·Filed 2018·Granted May 21, 2019·9 cites·29 claims
- 1196US10065968B2Crystalline forms of a bruton's tyrosine kinase inhibitorPHARMACYCLICS LLC·Filed 2018·Granted Sep 4, 2018·10 cites·22 claims
- 1295US10752634B2Crystalline forms of a brutons tyrosine kinase inhibitorPHARMACYCLICS LLC·Filed 2020·Granted Aug 25, 2020·3 cites·28 claims
- 1394US10266540B2Crystalline forms of a Bruton's tyrosine kinase inhibitorPHARMACYCLICS LLC·Filed 2018·Granted Apr 23, 2019·5 cites·23 claims
- 1493US8603521B2Formulations of histone deacetylase inhibitor and uses thereofLOURY DAVID J·Filed 2010·Granted Dec 10, 2013·11 cites·13 claims
- 1592US7547689B2Methods and compositions for treating atheroma, tumors and other neoplastic tissuesPHARMACYCLICS INC·Filed 2006·Granted Jun 16, 2009·12 cites·5 claims
- 1689US10105552B2Formulations of histone deacetylase inhibitor and uses thereofPHARMACYCLICS LLC·Filed 2016·Granted Oct 23, 2018·2 cites·15 claims
- 1788US9403032B2Formulations of histone deacetylase inhibitor and uses therofPHARMACYCLICS LLC·Filed 2013·Granted Aug 2, 2016·3 cites·17 claims
- 1888US2024409545A1Crystalline forms of a bruton's tyrosine kinase inhibitorPHARMACYCLICS LLC·Filed 2024·Application pending·0 cites
- 1979US2022112196A1Crystalline forms of a brutons tyrosine kinase inhibitorPHARMACYCLICS LLC·Filed 2021·Application pending·0 cites
- 2077US8552046B2Manufacture, compositions and uses of coagulation factor VIIa modulatorLOURY DAVID·Filed 2008·Granted Oct 8, 2013·2 cites·17 claims
- 2177US2021032258A1Crystalline forms of a brutons tyrosine kinase inhibitorPHARMACYCLICS LLC·Filed 2020·Application pending·0 cites
- 2276US2019248799A1Crystalline forms of a bruton's tyrosine kinase inhibitorPHARMACYCLICS LLC·Filed 2019·Application pending·0 cites
- 2376US2019248798A1Crystalline forms of a bruton's tyrosine kinase inhibitorPHARMACYCLICS LLC·Filed 2019·Application pending·0 cites
- 2475US2020231595A1Crystalline forms of a brutons tyrosine kinase inhibitorPHARMACYCLICS LLC·Filed 2020·Application pending·0 cites
- 2575US2020148691A1Crystalline forms of a brutons tyrosine kinase inhibitorPHARMACYCLICS LLC·Filed 2020·Application pending·0 cites
- 2673US9492423B2Formulations of histone deacetylase inhibitor in combination with bendamustine and uses thereofLOURY DAVID J·Filed 2011·Granted Nov 15, 2016·1 cites·9 claims
- 2772US2018155352A1Crystalline forms of a bruton's tyrosine kinase inhibitorPHARMACYCLICS LLC·Filed 2018·Application pending·0 cites
- 2872US2018170940A1Crystalline forms of a bruton's tyrosine kinase inhibitorPHARMACYCLICS LLC·Filed 2018·Application pending·0 cites
- 2971US2017305919A1Crystalline forms of a bruton's tyrosine kinase inhibitorPHARMACYCLICS LLC·Filed 2017·Application pending·0 cites
- 3070US2014336203A1Crystalline forms of a bruton's tyrosine kinase inhibitorPHARMACYCLICS INC·Filed 2014·Application pending·0 cites
- 3166US2014039022A1Manufacture, compositions and uses of coagulation factor viia modulatorPHARMACYCLICS INC·Filed 2013·Application pending·0 cites
- 3264US2019184196A1Formulations of histone deacetylase inhibitor and uses thereofPHARMACYCLICS LLC·Filed 2018·Application pending·0 cites
- 3363US2015164854A1Formulations of histone deacetylase inhibitor and uses therofPHARMACYCLICS INC·Filed 2015·Application pending·0 cites
- 3446US2011046100A1Texaphyrin solutions and pharmaceutical formulationsPHARMACYCLICS INC·Filed 2010·Application pending·0 cites
- 3544US2007078119A1Storage system for texaphyrin pharmaceutical formulationsPHARMACYCLICS INC·Filed 2005·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Norbert Purro files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →